ACTIVE

INTERNATIONALE APOTHEEK

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-24,2 k €-207,2 %over 1 year
Gross margin117,5 k €-16,7 %over 1 year
Equity190,1 k €-11,3 %over 1 year
Workforce2,2 ETP+4,8 %over 1 year

Identity

Source · BCE/KBO

INTERNATIONALE APOTHEEK is a Public limited company incorporated in 1952. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 2,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0404.790.106
Incorporation
17/03/1952
Legal form
Public limited company
Registered office
Appelmansstraat 11
2018 Antwerpen · FlandreSee on map
Contributed capital
65 000,00 €
Latest accounts
31/12/2025
Average workforce
2,2 ETP
Joint committees (1)
  • 313
Signals
Solid equityGood liquidityHealthy social debts

Financials

Source · NBB, 49 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin117,5 k €141,1 k €175,7 k €175,8 k €116,2 k €
EBITDA-10 k €41,1 k €69,7 k €103 k €57,2 k €
Operating result-18,8 k €31,8 k €49,4 k €76,3 k €30 k €
Net result-24,2 k €22,6 k €39,3 k €62,8 k €34,5 k €
Balance sheet
Equity190,1 k €214,3 k €214,3 k €214,3 k €214,3 k €
Total assets483 k €587,7 k €624,2 k €755,5 k €695,2 k €
Cash111,4 k €43,3 k €109,9 k €158,3 k €198,4 k €
Debts292,2 k €373,4 k €410 k €541,1 k €480,7 k €
Other
Workforce2,2 ETP2,1 ETP2,3 ETP1,4 ETP1,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Active
Jeff Roskams Consulting

Director · 0699.953.483

Represented by Jeff ROSKAMS

Active

Ended mandates

ANTWERP PHARMACIES

Managing director · since 01 mai 2021 · until 30 avril 2027 · 0700.733.344

Ended
ANTWERP PHARMACIES

Managing director · since 01 mai 2021 · until 30 avril 2027 · 0700.733.344

Ended
Jeff Roskams Consulting

Director · since 01 mai 2021 · until 30 avril 2027 · 0699.953.483

Ended
Jeff Roskams Consulting

Director · since 01 mai 2021 · until 30 avril 2027 · 0699.953.483

Represented by Jeff Roskams

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/06/202603/06/202506/06/202409/06/202309/06/202227/05/2021
General meeting26/05/202627/05/202528/05/202430/05/202331/05/202225/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 49 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/05/202615/06/2026DutchPDF
Abridged model31/12/202427/05/202503/06/2025DutchPDF
Abridged model31/12/202328/05/202406/06/2024DutchPDF
Abridged model31/12/202230/05/202309/06/2023DutchPDF
Abridged model31/12/202131/05/202209/06/2022DutchPDF
Abridged model31/12/202025/05/202127/05/2021DutchPDF
Abridged model31/12/201926/05/202010/06/2020DutchPDF
Abridged model31/12/201828/05/201912/06/2019DutchPDF
Abridged model31/12/201729/05/201825/06/2018DutchPDF
Abridged model31/12/201630/05/201728/06/2017DutchPDF
Abridged model31/12/201531/05/201602/06/2016DutchPDF
Abridged model31/12/201426/05/201524/06/2015DutchPDF
Abridged model31/12/201327/05/201423/06/2014DutchPDF
Abridged model28/02/201331/08/201327/09/2013DutchPDF
Abridged model29/02/201221/08/201211/09/2012DutchPDF
Abridged model28/02/201106/09/201130/09/2011DutchPDF
Abridged model28/02/201017/08/201006/09/2010DutchPDF
Abridged model28/02/200908/09/200906/10/2009DutchPDF
Abridged model28/02/200809/09/200801/10/2008DutchPDF
Abridged model28/02/200728/08/200703/10/2007DutchPDF
Abridged model28/02/200611/07/200631/07/2006DutchPDF
Abridged model28/02/200508/07/200502/08/2005DutchPDF
Abridged model29/02/200415/06/200409/07/2004DutchPDF
Abridged model28/02/200317/06/200315/07/2003DutchPDF

View all 49 filings

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Active
Jeff Roskams Consulting

Director · 0699.953.483

Represented by Jeff ROSKAMS

Active

Ended mandates

ANTWERP PHARMACIES

Managing director · since 01 mai 2021 · until 30 avril 2027 · 0700.733.344

Ended
ANTWERP PHARMACIES

Managing director · since 01 mai 2021 · until 30 avril 2027 · 0700.733.344

Ended
Jeff Roskams Consulting

Director · since 01 mai 2021 · until 30 avril 2027 · 0699.953.483

Ended
Jeff Roskams Consulting

Director · since 01 mai 2021 · until 30 avril 2027 · 0699.953.483

Represented by Jeff Roskams

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other02/06/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING
    PDF
  • Mandates19/10/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/01/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/10/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares27/12/2013
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates29/05/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/01/2007
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/12/2005
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-24,2 k €↓
  2. 2024
    Annual accounts 202422,6 k €↓
  3. 2023
    Annual accounts 202339,3 k €↓
  4. 2022
    Annual accounts 202262,8 k €↑
  5. 2021
    Annual accounts 202134,5 k €↑
  6. 2020
    Annual accounts 202029,7 k €↓
  7. 2019
    Annual accounts 201930,8 k €↑
  8. 2018
    Annual accounts 2018-50,7 k €↓
  9. 2017
    Annual accounts 2017-9,6 k €↓
  10. 2016
    Annual accounts 201647,7 k €↑
  11. 2015
    Annual accounts 201544,9 k €↓
  12. 2014
    Annual accounts 201472,3 k €↑
  13. 2013
    Annual accounts 20137,2 k €↓
  14. 2013
    Annual accounts 201312,4 k €↓
  15. 2012
    Annual accounts 201214,6 k €↓
  16. 2011
    Annual accounts 201139,4 k €↑
  17. 2010
    Annual accounts 201032,3 k €↑
  18. 2009
    Annual accounts 200927,5 k €↓
  19. 2008
    Annual accounts 200832,8 k €↑
  20. 2007
    Annual accounts 200716,9 k €
  21. 17/03/1952
    IncorporationPublic limited company